Table 2. Mean baseline and week 12 FVC (% predicted) in all GALS-001 patients.

N = number of patients. ¹P-values were calculated by two-sample t Test. ²The P-value was obtained from a Wilcoxon Rank Sum Test. ( Dataset 11).

Time Point	Placebo	GM604
Baseline
N	4	7
Mean FVC % Predicted	81.3	91.1
Week 12	4	7
Mean FVC % Predicted	69.8	86.4
Change from Baseline
N	4	7
Mean FVC % Predicted change	-11.5	-4.7
P-values 1 Two sample t Test		0.5393
P-values 2 Wilcoxon Rank Sum Test		>0.9999